N-Power Medicine is a clinical research and drug development platform company that aims to dramatically boost clinical trial participation to accelerate oncology drug development - and deliver on the promise of bringing life-saving innovation to cancer patients. Founded in 2021, the company addresses critical challenges for oncology sites by integrating technology and trained personnel into routine care to unlock the full potential of the data needed to bring new therapies to patients sooner.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 07/01/24 | undisclosed | Series B |
Merck Global Health Innovation Fund | undisclosed |
